Home > Healthcare > Medical Devices > Diagnostic Devices > GI Stool Testing Market

GI Stool Testing Market Size

  • Report ID: GMI5719
  • Published Date: May 2023
  • Report Format: PDF

GI Stool Testing Market Size

GI Stool Testing Market size was valued at around USD 600.1 million in 2022 and is estimated to reach over USD 1.2 billion by the end of 2032. The increasing prevalence of gastrointestinal diseases is anticipated to drive the market growth globally.

 

The rising incidence of colorectal cancer (CRC) is owing to factors including unhealthy lifestyle, diabetes, and ageing population, among others thereby driving market expansion. For instance, according to the reports published by the American Society of Clinical Oncology (ASCO), in 2020, approximately around 1,880,725 individuals were diagnosed with colorectal cancer across the globe

 

GI stool testing tests delivers certain clinical benefits over conventional diagnostic procedures, such as rapid specimen handling, simpler sample requirements, increased automation, and rapid results. As a result, the demand for GI stool testing is proliferating, especially in the emerging economies that possess immense market value. Moreover, the increased usage and demand for these testing procedures in hospital settings is expected to develop business growth opportunities.

 

GI stool testing products are utilized for the diagnosis of gastrointestinal diseases comprising infection, inflammatory bowel disease, gastroesophageal reflux disease (GERD), and cancer among others. These testing products include an occult blood test, parasites test, bacteria test, and fecal biomarkers test among others that are employed in the detection and treatment of certain gastrointestinal conditions.

 

However, gastrointestinal diseases can be diagnosed with different testing techniques comprising GI stool testing. These tests require accurate operational skills for precise diagnosis to evaluate appropriate treatment. Thus, the lack of skilled professionals in countries with limited healthcare resources can hamper the disease testing rate, thereby impacting the industry revenue.

 

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global market for GI stool testing was valued at USD 600.1 million in 2022 and will reach over USD 1.2 billion by 2032 propelled by factors including unhealthy lifestyles, rising occurrences of diabetes, and the aging population, among others.

The consumables segment was worth over USD 376 million in 2022 as a result of an increase in the preference for GI disease diagnostic reagents and test kits.

The gastrointestinal infection application segment dominated the market with more than 38% revenue share in 2022 owing to the growing prevalence of GI infection and preference for technologically advanced GI diagnostic tests.

The U.S. GI stool testing market was valued at USD 254 million in 2022 due to the strong presence of major industry players and the rising prevalence of gastrointestinal disorders in the country.

GI Stool Testing Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 16
  • Tables & Figures: 683
  • Countries covered: 30
  • Pages: 180
 Download Free Sample